Shane Olwill

Insider Reports History

Location
Boston, MA
Signature
/s/ Ahmed Mousa, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shane Olwill:

Company Role Class Num Shares Value Price $ Report Date Ownership
PIERIS PHARMACEUTICALS, INC. Chief Development Officer Stock Option (Right to buy) 249,080 24 Feb 2023 Direct

Insider Reports Filed by Shane Olwill

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PIRS PIERIS PHARMACEUTICALS, INC. 24 Feb 2023 1 $0 4 Chief Development Officer 28 Feb 2023, 16:23
PIRS PIERIS PHARMACEUTICALS, INC. 22 Feb 2022 1 $0 4 Chief Development Officer 24 Feb 2022, 15:47
PIRS PIERIS PHARMACEUTICALS, INC. 30 Aug 2021 4 -$138,012 4 Chief Development Officer 01 Sep 2021, 16:38
PIRS PIERIS PHARMACEUTICALS, INC. 01 Aug 2021 0 $0 3 Chief Development Officer 03 Aug 2021, 16:09